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Bactericidal activity of quinolones has been related to a combination of DNA
fragmentation, reactive oxygen species (ROS) production and programmed cell death
(PCD) systems. The underlying molecular systems responsible for reducing bactericidal
effect during antimicrobial therapy in low-level quinolone resistance (LLQR) phenotypes
need to be clarified. To do this and also define possible new antimicrobial targets,
the transcriptome profile of isogenic Escherichia coli harboring quinolone resistance
mechanisms in the presence of a clinical relevant concentration of ciprofloxacin was
evaluated. A marked differential response to ciprofloxacin of either up- or downregulation
was observed in LLQR strains. Multiple genes implicated in ROS modulation (related to
the TCA cycle, aerobic respiration and detoxification systems) were upregulated (sdhC
up to 63.5-fold) in mutants with LLQR. SOS system components were downregulated
(recA up to 30.7-fold). yihE, a protective kinase coding for PCD, was also upregulated
(up to 5.2-fold). SdhC inhibition sensitized LLQR phenotypes (up to 1Log = 2.3 after
24 h). At clinically relevant concentrations of ciprofloxacin, gene expression patterns in
critical systems to bacterial survival and mutant development were significantly modified
in LLQR phenotypes. Chemical inhibition of SdhC (succinate dehydrogenase) validated
modulation of ROS as an interesting target for bacterial sensitization.
Keywords: ciprofloxacin, low-level quinolone resistance, survival, transcriptomic, global response, sensitization
INTRODUCTION
Enterobacteriaceae, particularly Escherichia coli, are among the most common organisms causing
community, nosocomial, and opportunistic infections (Vila et al., 2016). Fluoroquinolones are
commonly used for empirical and directed therapy in infections caused by E. coli (Vila et al.,
2016). Over the past three decades, quinolone resistance in Enterobacteriaceae from human
and veterinary isolates has increased (Rodríguez-Martínez et al., 2016b). Known mechanisms of
fluoroquinolone resistance occur principally through chromosomal mutations in genes encoding
the quinolone targets (DNA gyrase and topoisomerase IV), and to a lesser extent through decreased
permeability (implicating upregulation of the AcrAB-TolC multidrug efflux pump) (Blair et al.,
2015; Hooper and Jacoby, 2015). Additionally, plasmid-mediated quinolone resistance (PMQR)
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mechanisms (Qnr proteins that protect the quinolone targets;
the acetylation of ciprofloxacin and norfloxacin by Aac(6′)-Ib-cr;
and the plasmid-mediated efflux pumps, QepA and OqxAB)
have also been described and are epidemiologically relevant
(Rodríguez-Martínez et al., 2011, 2016b; Jacoby et al., 2014).
All these determinants (chromosomal or plasmid mediated) on
their own confer low-level quinolone resistance (LLQR), and
multiple mechanisms must be combined to achieve clinical levels
of resistance (Morgan-Linnell and Zechiedrich, 2007; Morgan-
Linnell et al., 2009; Briales et al., 2011; Machuca et al., 2014).
It is of crucial medical importance to understand the
molecular mechanisms that promote the development of
antimicrobial resistance as well as to clarify the molecular
responses to antimicrobials that lead to the survival or death
of the cell (Palmer and Kishony, 2013; Baym et al., 2016).
The bactericidal activity of quinolones in bacteria has been
related to a combination of DNA fragmentation, reactive oxygen
species (ROS) production and programmed cell death (PCD)
systems mediated by toxin-antitoxin (TA) modules such as
mazEF (Drlica et al., 2009; Erental et al., 2014; Zhao et al., 2015).
The SOS system response has also been postulated as a formidable
strategy against aggressions such as antimicrobial exposure,
inducing the transient expression of mutational machinery
(Baharoglu and Mazel, 2014). The intensity and role of all
these processes implicated in survival and mutant emergence
would be proportional to drug concentration (and a function of
susceptibility levels directly related to MIC values).
The impact of LLQR mechanisms on the decreased
bactericidal effect of these antimicrobial agents and their
increased influence on the emergence of high-level resistance
seems to be clear. However, the underlying molecular systems
responsible for this phenomenon in clinical setting still need to
be clarified. In order to do this in terms of genetic expression,
this study evaluated the transcriptome profiling of isogenic
E. coli harboring frequent quinolone resistance mechanisms
(chromosomal and plasmid-mediated) in the presence of
clinically significant concentrations of ciprofloxacin (breakpoint
for reduced susceptibility which is near to 1/2 of serum Cmax)
(Mandell et al., 2010). We also evaluated enhancing ciprofloxacin




Escherichia coli ATCC R© 25922TM was used as the background
strain. This microorganism is a recommended CLSI control
strain used worldwide for antimicrobial susceptibility testing
(including quinolones). First, four LLQR isogenic strains
were tested using a global transcriptomic approach: ATCC
25922 (wild-type, MIC for ciprofloxacin 0.004 µg/mL); EC14
(E. coli ATCC 25922 coding for QnrS1, MIC for ciprofloxacin
0.125 µg/mL); EC19 (E. coli ATCC 25922 with deleted marR
gene and coding for QnrS1, MIC for ciprofloxacin 0.5 µg/mL);
and EC24 (E. coli ATCC 25922 with the Ser83Leu substitution
in GyrA and coding for QnrS1, MIC for ciprofloxacin 1 µg/mL)
(Table 1; Machuca et al., 2014). All of these were susceptible to
quinolones according to CLSI breakpoints (CLSI). Second, E. coli
ATCC 25922 and two isogenic mutants harboring chromosomal
and/or PMQR mechanisms (EC04: E. coli ATCC 25922 with
the Ser83Leu substitutions in GyrA and Ser80Arg in ParC, MIC
for ciprofloxacin 0.5 µg/mL; and EC59: E. coli ATCC 25922
with the Ser83Leu and Asp87Arg substitutions in GyrA and
Ser80Arg in ParC, deleted marR gene and coding for QnrS1,
MIC for ciprofloxacin 32 µg/mL) were used for sdhC (succinate
dehydrogenase complex subunit C) or cyoA (cytochrome oxidase
subunit II) inactivation, as described (Table 1; Datsenko and
Wanner, 2000; Machuca et al., 2014). qnrS1 gene was cloned into
pBK-CMV vector as described previously (Machuca et al., 2014).
Empty pBK-CMV vector was used as control and also introduced
into E. coli ATCC 25922 and EC04 for comparison.
Experimental Conditions and Microarray
RNA Analysis
Escherichia coli ATCC 25922 (wild-type) and isogenic EC14,
EC19, EC24 (LLQR) strains were tested to evaluate the global
response to relevant fixed concentrations of ciprofloxacin
(1 µg/mL, the breakpoint for reduced susceptibility according
to CLSI and near to 1/2 of serum Cmax) (Mandell et al.,
2010). Transcriptomic profile of E. coli ATCC 25922 was also
compared to EC14 in absence of ciprofloxacin as control. All
were susceptible to quinolones according to CLSI breakpoints
(CLSI). Cultures were started from single colonies and grown
overnight in 25 ml of LB (Luria Bertani medium, Becton
Dickinson, Le Pont-de-Claix, France). These cells were diluted
1:100 and grown to cell concentrations of 4x108 cells/ml
(OD600 nm = 0.4, exponential phase) for treatment. Three
biological replicates per genotype were incubated at 1 µg/mL
ciprofloxacin for 60 min (i.e., 250xMIC for E. coli ATCC
25922, 8xMIC for EC14, 2xMIC for EC19 and 1xMIC for
EC24). Approximately 109 cells (2 ml) were taken for RNA
isolation. The pellet was processed immediately. The pellet
was pre-incubated in RNAprotect Bacteria Reagent (Qiagen,
Hilden, Germany). RNA extraction was performed using the
RNeasy Mini Kit (Qiagen, Hilden, Germany). Contaminating
DNA was removed from RNA samples with TURBO DNA-free
(Ambion, United States). The RNA concentration was measured
using NanoDrop ND-1000 (Thermo Scientific). The integrity
of the RNA samples was analyzed with the BioAnalyzer 2100
(Agilent Technologies) using the RNAnano 6000 kit (Agilent
Technologies). Labeling, microarray hybridization, scanning, and
data processing were performed in the Genomics Unit of the
Centro Nacional de Biotecnología1. The data obtained from each
LLQR mutant was always compared with the E. coli ATCC
25922 wild-type strain. The FIESTA program was used for
analysis2 and the p-value was determined according to the FDR
algorithm (p < 0.05 was considered significant). Microarray





Frontiers in Microbiology | www.frontiersin.org 2 July 2017 | Volume 8 | Article 1370
fmicb-08-01370 July 17, 2017 Time: 15:8 # 3
Machuca et al. Response to Ciprofloxacin in LLQR Escherichia coli
TABLE 1 | Bacterial strains used in this study and ciprofloxacin susceptibility.
Strain Genetic description CIPa Use in this study Reference
E. coli ATCC 25922 Wild-type E. coli 0.004 Transcriptomic assays 7
EC14 E. coli ATCC 25922 coding for QnrS1 0.125 Transcriptomic assays 7
EC19 E. coli ATCC 25922 with deleted marR gene and coding for QnrS1 0.5 Transcriptomic assays 7
EC24 E. coli ATCC 25922 with the substitution Ser83Leu in GyrA and coding
for QnrS1
1 Transcriptomic assays 7
EC04 E. coli ATCC 25922 with the Ser83Leu substitution in GyrA and
Ser80Arg in ParC
0.5 Viability assays (Killing curves) 7
EC59 E. coli ATCC 25922 with substitutions Ser83Leu+Asp87Asn in GyrA,
Ser80Arg in ParC, the deleted marR gene and coding for QnrS1
32 Viability assays (Killing curves) 7
E. coli ATCC 25922 1sdhC E. coli ATCC 25922 with sdhC deleted 0.004 Viability assays (Killing curves) This study
E. coli ATCC 25922 1cyoA E. coli ATCC 25922 with cyoA deleted 0.004 Viability assays (Killing curves) This study
EC04 1sdhC E. coli ATCC 25922 with substitutions Ser83Leu in GyrA and Ser80Arg
in ParC with deleted sdhC
0.5 Viability assays (Killing curves) This study
EC04 1cyoA E. coli ATCC 25922 with substitutions Ser83Leu in GyrA and Ser80Arg
in ParC with deleted cyoA
0.5 Viability assays (Killing curves) This study
EC59 1sdhC E. coli ATCC 25922 with substitutions Ser83Leu+Asp87Asn in GyrA,
Ser80Arg in ParC, deleted marR gene and coding for QnrS1 with
deleted sdhC
32 Viability assays (Killing curves) This study
EC59 1cyoA E. coli ATCC 25922 with the substitutions Ser83Leu+Asp87Asn in
GyrA, Ser80Arg in ParC, deleted marR gene and coding for QnrS1
32 Viability assays (Killing curves) This study
With deleted cyoA
aMIC (µg/mL) of ciprofloxacin.
Annotation of Gene Functions and
Regulation
Gene functions (COG, Clusters of Orthologous Groups) (Tatusov
et al., 2000) were identified using the following bioinformatics
resources for E. coli: ECOCYC4, ECOGENE5, Gene Expression
Database6, KEGG7, BPROM8, and DAVID9. Venn diagrams were
created using the http://bioinfogp.cnb.csic.es/tools/venny/index.
html website.
Microarray RNA Data Validation
Real time RT-PCR was used, as described (Rodríguez-Martínez
et al., 2012), to confirm specific transcriptome data (sdhC, sucD,
nouH, recA, focA, tnaA genes), both in presence and absence
of ciprofloxacin. The LightCycler FastStart DNA Master SYBR
Green I Kit (Roche) was used for amplification. To normalize
expression levels, target gene transcripts were calculated relative
to the mdh gene, using the 2−11CT method. The primers used
for gene amplification are indicated in Supplementary Table 1.
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility was determined by microdilution
according to CLSI guidelines (CLSI). The quinolones tested were
ciprofloxacin, norfloxacin, ofloxacin, levofloxacin, moxifloxacin









Potentiating antibacterial activity by enhancing microbial ROS
production has been demonstrated previously (Brynildsen et al.,
2013). To test the impact of ROS modulation (by sdhC or
cyoA deletion) on bacterial viability in E. coli ATCC 25922,
EC04 and EC59 strains, time-kill curves were assayed in
MHB (Mueller-Hinton broth, Becton Dickinson, Le Pont-de-
Claix, France) at ciprofloxacin and ofloxacin concentrations of
2xMIC (Table 1). Growth in drug-free broth was evaluated in
parallel, as a control. Cultures were incubated at 37◦C, and
shaken at 180rpm. An initial inoculum of 106 CFU/mL from
a fresh overnight culture was used in all experiments. Bacterial
concentrations were determined at 0, 1, 2, 3, 4, and 24 h by colony
counting on drug-free agar.
In parallel, the time courses of E. coli ATCC 25922, EC04
and EC59 cells treated with carboxin (500 µM), an inhibitor
of succinate dehydrogenase (Brynildsen et al., 2013), and a
fluoroquinolone (ciprofloxacin or ofloxacin at 2xMIC), were
compared with treatment with fluoroquinolones alone. Carboxin
(Sigma–Aldrich, Madrid, Spain) was dissolved in 100% ethanol
(Brynildsen et al., 2013).
RESULTS
Global Expression Profiles
In order to establish the role of LLQR phenotypes on the
differential expression in response to quinolones, the expression
profiles of isogenic E. coli carrying LLQR harboring frequent
chromosomal and PMQR mechanisms (EC14 coding for QnrS1;
EC19 with deleted marR gene and coding for QnrS1; and
EC24 with the Ser83Leu substitution in GyrA and coding
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FIGURE 1 | Global expression profiles of cells with low-level quinolone
resistance (LLQR) exposed to 1 µg/mL of ciprofloxacin and compared with
the wild-type cells in the same conditions. (A) Number of differentially up- and
downregulated genes (≥ or ≤5-fold) in the presence of ciprofloxacin
(1 µg/mL) in LLQR cells compared to wild-type cells in the same conditions.
(B) Number of genes up- or downregulated, grouped according to the factor
of differential expression in LLQR cells compared to the wild-type cells in the
same conditions. Genes were included when differences were significant
(p < 0.05). EC14 means E. coli ATCC 25922 pBK-QnrS1; EC19 means E. coli
ATCC 25922 1marR pBK-QnrS1; and EC24 means E. coli ATCC 25922
S83L pBK-QnrS1.
for QnrS1) (Machuca et al., 2014) were evaluated in the
presence of significant clinical concentrations of ciprofloxacin
(1 µg/mL, the breakpoint for reduced susceptibility according
to CLSI and near to 1/2 of serum Cmax) (Mandell et al.,
2010; Clinical and Laboratory Standards Institute [CLSI],
2016) and compared with those of wild-type E. coli ATCC
25922 (Figure 1 and Supplementary Tables 2, 3). The MIC
values of ciprofloxacin for these susceptible LLQR strains
(EC14, EC19, EC24) were 32-, 125- and 250-fold higher
compared to the wild-type strain. As expected, significant
differences were observed in the numbers of differentially
up- and downregulated genes (>5-fold, p < 0.05). Most genes
were upregulated and the differences were proportional to
the MIC values for strains with LLQR (EC14: 452/203 genes;
EC19: 574/256 genes; EC24: 695/381 genes, upregulated and
downregulated, respectively) (Figure 1A). Expression of
>2500 genes, whether by upregulation or downregulation,
varied more than > 2-fold, reflecting the marked differential
response to ciprofloxacin in LLQR strains. Under these
this clinically significant concentration of ciprofloxacin,
variations of > 10-fold for EC14/EC19/EC24 (271/339/450
genes), of > 50-fold (34/32/68 genes) and of > 100-fold
(8/8/33 genes) were observed (Figure 1B). Just a few
genes had differential expression of more than 200-fold
for LLQR cells compared to the wild-type (16 genes for
EC24).
Figure 2 shows gene expression classified according to the
COG functional categories (Tatusov et al., 2000) (showing
values equal to or more than 30-fold, that is, large differences,
p-value < 0.05) (see also Supplementary Table 3). Among these
genes, four functional groups were chiefly affected, related to the
number of genes involved. “Energy production and conversion
genes (EPC)” and “Amino acid metabolism and transport
genes (AMT)” tended to be genes upregulated at higher levels
(≥30-fold). These differences were proportional to MIC values
for strains with LLQR (EC14: 9/4 genes; EC19: 15/11 genes; EC24:
41/24 genes for EPC and AMT genes, respectively) (Figure 2).
A reduction of genes related to “Bacteriophage Activation (BA)”
was observed counter to MIC values for LLQR strains (mostly
upregulated in EC14 and EC19) (Figure 2), while there was a
considerable number of highly altered genes without functional
prediction (both up- and downregulated).
Figure 3 shows differentially expressed genes equal to or
greater than 30-fold (p-value < 0.05) (regarded as major
differences in terms of expression). Interestingly, the strains
with LLQR were proportionally reorganized in response to
ciprofloxacin stress (Figure 3). In this regard, 141 genes showed
altered expression for at least one strain with LLQR, and
14.9% of these were shared in all three strains. In total, under
ciprofloxacin-induced stress, 25 and 47 genes were specifically
affected in EC14 and EC24, respectively, while neither of these
strains shared any genes with altered expression. EC19, on the
other hand, shared 20 and 27 genes with EC14 and EC24,
respectively. These data indicate that, with respect to EC14
and EC24, EC19 is at a transitional stage in its response to
ciprofloxacin (see also Supplementary Table 3).
The transcriptome microarray data for six specific genes
was validated by quantitative RT-PCR, confirming both
the upregulation and downregulation results in presence of
ciprofloxacin (Supplementary Table 1). No significant differences
were observed for these genes in absence of ciprofloxacin (data
not shown). No significant differences were observed when
E. coli ATCC 25922 and EC14 were compared in absence of
ciprofloxacin (data not shown).
Increased ROS Modulation in Isogenic
E. coli with LLQR
Multiple genes implicated in oxidative metabolism and
modulation of ROS [related to the TCA cycle (sdhC: Succinate
dehydrogenase; pta: Phosphotransacetylase; sucA-D: Succinyl
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FIGURE 2 | Gene expression classified by COG (Cluster of Orthologous Groups) (Tatusov et al., 2000) for functional categories (greater than or equal to 30-fold,
p-value < 0.05).
CoA synthase complex; up to 495-fold), aerobic respiration
(cyoA-E: Cytochrome oxidase; nuoG or nuoH: Ubiquinone
oxidoreductase; atpH: ATP synthase; up to 108-fold),
glucose metabolism (gnd: Gluconate-P dehydrogenase; zwf :
Glucose-6-phosphate 1-dehydrogenase; up to 5.5-fold) or
detoxification systems (dps: Stress-induced Fe-binding, ahpC:
Alkyl hydroperoxide reductase, sodB: Superoxide dismutase,
katG: Catalase-peroxidase; up to 12.4-fold)] were highly
upregulated in LLQR mutants (Figure 4 and Supplementary
Table 2). Proteome profiling based on LC-MS/MS (liquid
chromatography–mass spectrometry) showed a similar trend
with proteins related to ROS modulation over-represented in
LLQR mutants (Supplementary Table 4). Differences observed
were proportional to MIC values for strains with LLQR. These
data indicate that strains with LLQR would produce lower levels
of ROS in the presence of clinical concentrations of ciprofloxacin
(Brynildsen et al., 2013; Dwyer et al., 2014).
Moderate SOS Response in Isogenic
E. coli with LLQR
Genes involved in DNA repair and the SOS response are highly
upregulated in response to quinolones (Dwyer et al., 2007;
Baharoglu and Mazel, 2014). In our experiment, the relative
concentrations of ciprofloxacin used were 250xMIC for E. coli
ATCC 25922, 8xMIC for EC14, 2xMIC for EC19 and 1xMIC
for EC24. Under this clinically significant concentration of
ciprofloxacin, a clear reduction of SOS system gene expression
was observed in strains with LLQR [related to SOS system
activation (recA: the multifunctional DNA recombination and
repair protein and master regulator of the SOS system; up to
−30.7-fold), DNA repair by homologous recombination (ruvA:
Holliday junction recognition protein; up to −4.75-fold), DNA
nucleotide excision repair (uvrB: Excision nuclease subunit B; up
to −20.3-fold) or DNA repair by translesion synthesis (umuC:
Translesion DNA polymerase V; up to−7.9-fold)] (Figure 5 and
Supplementary Table 2).
Impact of LLQR Phenotypes on Other
Bacterial Survival Systems
The PCD and TA systems have been linked to cell death in
response to quinolones (Erental et al., 2012, 2014). We analyzed
patterns of expression of multiple TA systems (both type I and
type II) and found both upregulated (gnsA, ymcE, yjhQ, yjhX, or
yihE) and downregulated genes (hokA, hokD, symE, chpBK, yhaV,
yefM, yoeB, or yfjF) in strains with LLQR (Yamaguchi and Inouye,
2011). Interestingly, the yihE gene (coding for a key kinase
regulator that protects E. coli from antimicrobials like quinolones
by antagonizing the MazEF TA module) was upregulated in
LLQR strains (Supplementary Figure 1 and Table 2) (Dorsey-
Oresto et al., 2013).
Altered expression of downstream genes linked to the
mazEF pathway involved in PCD control was also detected
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FIGURE 3 | Overlap between differently expressed genes (greater than or
equal to 30-fold, p-value < 0.05) on exposure to ciprofloxacin (1 µg/mL)
between low-level quinolone resistant (LLQR) cells compared to the wild-type
cells in the same conditions. Venn diagram shows the overlap. The numbers
indicated on the diagram refer to the number of genes with significantly
altered expression levels in one or both conditions. LLQR phenotypes: EC14
means E. coli ATCC 25922 pBK-QnrS1; EC19 means E. coli ATCC 25922
1marR pBK-QnrS1; and EC24 means E. coli ATCC 25922 S83L pBK-QnrS1.
(Erental et al., 2014). yfiD, clpX, clpP, and yfbU were upregulated;
slyD and ygcR were downregulated in strains with LLQR.
Interestingly, genes for the major quinolone target in
Gram-negative bacteria, the DNA gyrase subunits, tended
to be downregulated (gyrA: DNA gyrase, subunit A, up to
−7.18-fold and gyrB: DNA gyrase, subunit B, up to −8.9-fold)
in strains with LLQR. Finally, several genes implicated in the
DNA mismatch repair system tended to be downregulated
(mutH: up to −2.84-fold; mutL: up to −2.14-fold; mutM: up to
−5.57-fold; mutY : up to −4.03-fold) in LLQR strains. mutS was
not significantly affected (Supplementary Figure 1 and Table 2).
Sensitization of LLQR Phenotypes by
Targeting Oxidative Metabolism
The transcriptomic data obtained indicated that oxidative
metabolism (related to the endogenous production of ROS
and detoxification systems) plays an important and differential
role in quinolone response in strains with LLQR. We tested
the impact of sdhC (Succinate dehydrogenase component)
and cyoA (Cytochrome O oxidase component) deletions on
bacterial viability. Inhibiting these two targets has previously
been shown to enhance endogenous microbial ROS production
and potentiate the antibacterial activity of quinolones in full
susceptible wild-type E. coli (Brynildsen et al., 2013). Here, we
tested its putative role in terms of LLQR phenotype sensitization.
In terms of time-kill curves (assayed in MHB at ciprofloxacin
and ofloxacin concentrations of 2xMIC), sdhC deletion increased
sensitivity to fluoroquinolones (both ciprofloxacin and ofloxacin)
in wild-type and LLQR strains (Figure 6). A marked reduction in
viable bacteria counts was observed for ciprofloxacin after a short
incubation (E. coli ATCC 25922: 1Log= 1.4, EC04: 1Log= 1.5,
EC59: 1Log = 0.4; after 4 h) and a long one (E. coli ATCC
25922: 1Log = 0.6, EC04: 1Log = 1.4, EC59: 1Log = 2.3; after
24 h). Although it has been suggested that cyoA is implicated in
the quinolone sensitization process in E. coli (Brynildsen et al.,
2013), only a minor impact was observed in our study in terms of
expression (data not shown).
We also wondered whether chemical inhibition of this
validated target (sdhC) would increase sensitivity to these
bactericidal antimicrobial agents. We treated wild-type
and LLQR strains with carboxin, an inhibitor of succinate
dehydrogenase (Brynildsen et al., 2013), and measured their
susceptibility to ciprofloxacin and ofloxacin, respectively.
The addition of carboxin alone had no effect on the growth
of wild-type cells (data not shown). However, wild-type
and LLQR cells treated with fluoroquinolones and carboxin
demonstrated increased sensitivity compared to cells treated
with fluoroquinolones alone. For ciprofloxacin, this reduction in
viability was observed after a short period of incubation (E. coli
ATCC 25922: 1Log= 1.1, EC04: 1Log= 0.9, EC59: 1Log= 0.6;
after 4 h) and a long one (E. coli ATCC 25922: 1Log= 0.6, EC04:
1Log= 0.3, EC59: 1Log= 2.2; after 24 h) (Figure 6).
DISCUSSION
Using a transcriptomic approach, we provided evidence of the
differential response at clinically significant concentrations of
ciprofloxacin (1 µg/mL, the breakpoint for reduced susceptibility
according to CLSI and near to 1/2 of serum Cmax) (Mandell et al.,
2010) in E. coli strains with LLQR harboring frequent quinolone
resistance mechanisms (chromosomal and plasmid-mediated).
This reduced susceptibility observed in LLQR phenotypes
(directly related to MIC value and independently of the
subjacent molecular mechanism) led to modulation of multiple
systems contributing to bacterial survival under this therapeutic
concentration. Additionally, this approach resulted to be useful
to start the study of new potential targets for LLQR strains
sensitization by targeting ROS modulation.
Ciprofloxacin caused a major reprogramming of gene
expression across the genome: hundreds of genes exhibited
upregulation or downregulation (Figures 1, 2 and Supplementary
Tables 2, 3), supporting previous literature for quinolones and
other antimicrobials (Shaw et al., 2003; Peter et al., 2004;
Kohanski et al., 2007, 2010; Ferrándiz et al., 2016). Although
it has been reported that both specific GyrA substitutions
(Asp87Gly), marR gene deletion or qnrS expression may modify
moderately the expression of several genes in bacteria (Seoane
and Levy, 1995; Okumura et al., 2011; Kwak et al., 2013; Webber
et al., 2013), this aspect had not a relevant impact in the
interpretation of our results. Phenotypes with LLQR possessed a
marked differential response to ciprofloxacin, and the differences
observed were proportional to the MIC values for LLQR strains.
One of the processes most affected was related to oxidative
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FIGURE 4 | Impact on ROS response of low-level quinolone-resistant (LLQR) cells exposed to 1 µg/mL of ciprofloxacin compared to wild-type cells in the same
conditions. LLQR phenotypes: EC14 means E. coli ATCC 25922 pBK-QnrS1; EC19 means E. coli ATCC 25922 1marR pBK-QnrS1; and EC24 means E. coli ATCC
25922 S83L pBK-QnrS1. All indicated genes show a significantly different pattern of expression between LLQR strains and wild-type E. coli (p-value < 0.05).
Standard deviations were within 10% of the means.
FIGURE 5 | Impact on SOS response of low-level quinolone-resistant (LLQR) cells exposed to 1 µg/mL of ciprofloxacin, compared to wild-type cells in the same
conditions. LLQR phenotypes: EC14 means E. coli ATCC 25922 pBK-QnrS1; EC19 means E. coli ATCC 25922 1marR pBK-QnrS1; and EC24 means E. coli ATCC
25922 S83L pBK-QnrS1. All indicated genes shown a pattern of expression significantly different among LLQR strains and wild-type E. coli (p-value < 0.05).
Standard deviations were within 10% of the means.
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FIGURE 6 | Evaluation of susceptibility to killing by ciprofloxacin (A–C), ofloxacin (D–F), and combination treatments with carboxin (500 µM). Fluoroquinolone
concentrations tested were equivalent to 2xMIC values. Data are plotted as mean ± standard deviation.
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metabolism. It has already been shown that the antibacterial
activity of antibiotics such as quinolones can be increased by
potentiating endogenous microbial ROS production (Wang and
Zhao, 2009; Brynildsen et al., 2013). Our results are consistent
with these studies and indicate that strains with LLQR would
produce lower levels of ROS (Brynildsen et al., 2013; Dwyer et al.,
2014). At clinically significant concentrations of ciprofloxacin,
the quinolone-induced complex redox alterations downstream
of their target-specific interactions that contribute to cellular
damage and death would be reduced in strains with LLQR
(Erental et al., 2012; Brynildsen et al., 2013; Dorsey-Oresto et al.,
2013; Dwyer et al., 2014; Händel et al., 2014, 2016; Méhi et al.,
2014; Ferrándiz et al., 2016). In this context, resistance would be
the result on interaction at the genetic and gene expression levels
(Händel et al., 2014; Freihofer et al., 2016).
In E. coli, RecA-LexA coordinates the DNA damage response
that allows two opposing responses: life, mediated by the SOS;
and death, mediated by the PCD (Baharoglu and Mazel, 2014;
Erental et al., 2014). The choice seems to depend on the degree
of DNA damage to the cell (and is indirectly a function of
MIC values) (Rodríguez-Martínez et al., 2016a). At 1 µg/mL of
ciprofloxacin, LLQR strains would be affected by stress caused
by moderate DNA damage compared to the stress in wild-type
E. coli caused by a severe DNA damage. Moderate SOS response
in LLQR strains could lead to survival, while massive DNA
damage in wild-type E. coli could lead to dead population under
exacerbated SOS response (Erental et al., 2014). At clinically
significant concentrations of ciprofloxacin, the evolution to
clinical resistance (ciprofloxacin MIC higher than 2 µg/mL)
would be favored in the strain with LLQR, allowing survival
and favoring processes of recombination and DNA repair, such
as translesion synthesis (Morgan-Linnell and Zechiedrich, 2007;
Morgan-Linnell et al., 2009; Baharoglu and Mazel, 2014; Erental
et al., 2014). These data would support the higher frequency of
mutants observed in LLQR strains (Briales et al., 2011; Machuca
et al., 2014).
Furthermore, the expression profile was clearly altered in
these LLQR strains, and involved even TA system genes,
PCD genes and MMR genes. Interestingly, the yihE gene
(coding for a key kinase regulator that protects E. coli from
antimicrobials like quinolones by antagonizing the MazEF TA
module) was upregulated in LLQR strains (Dorsey-Oresto et al.,
2013), increasing the level of protection against PCD processes.
Downregulation of the DNA gyrase genes (both gyrA and gyrB)
also inferred the differential degree of stress in strains with LLQR
compared to the wild-type strains (Supplementary Figure 1).
The redox stress component of antibiotic lethality contributes
to cell death (usually without MICs values modification) (Wang
and Zhao, 2009; Brynildsen et al., 2013). More specifically,
antimicrobials like quinolones produce alterations to the central
metabolism, cellular respiration and iron metabolism initiated
by drug-mediated disruptions of target-specific processes and
resulting in cellular damage (Dwyer et al., 2014; Zhao and Drlica,
2014; Lobritz et al., 2015; Zhao et al., 2015). Drug tolerance in
pathogenic clinical isolates involves mutations in the oxidative
stress response and detoxifying genes (McMurry et al., 1998;
Koutsolioutsou et al., 2005; Páez et al., 2010; Thomas et al., 2013).
Our transcriptomic data indicated that oxidative metabolism
(related both to endogenous ROS modulation and detoxification
systems) plays an important differential role in the response of
quinolones in LLQR strains. Here we hypothesized that, against
quinolones, the deletion or inhibition of the central components
of the TCA cycle would lead to sensitization in strains with LLQR
similar to that observed in fully susceptible wild-type E. coli, as
previously described (Brynildsen et al., 2013).
Our results show that inhibiting succinate dehydrogenase
(predictable according to transcriptomic comparisons) is
sufficient to increase sensitivity to quinolones in LLQR E. coli.
Although carboxin may not be useful as an antibiotic adjuvant
because of its toxicity10, the data reinforce the potential
usefulness of this strategy.
In summary, the global response to ciprofloxacin is
significantly altered in LLQR E. coli and affects critical systems
for survival and the emergence of antimicrobial resistance at
clinically relevant concentrations. This approach validated ROS
modulation as an interesting target in bacterial re-sensitization
after drug resistance development.
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